Gaudium IVF Monitoring Agency Report Confirms Nil Deviation In IPO Proceeds Utilization
Gaudium IVF and Women Health Ltd 路 Others (Uncategorized) 路 13 Nov 2026, 5:08 am
Gaudium IVF Monitoring Agency Report Confirms Nil Deviation In IPO Proceeds Utilization Infomerics Valuation and Rating released the Monitoring Agency Report for Gaudium IVF and Women Health for the quarter ended 30th Sep'26, confirming nil material deviation from stated IPO objects. Out of total gross fresh issue proceeds of Rs 90.00 crore, cumulative utilization reached Rs 50.65 crore (Rs 16.62 crore utilized during the quarter), leaving Rs 39.35 crore unutilized, primarily held in HDFC Bank fixed deposits. The Board approved reallocating an unutilized borrowing repayment balance of Rs 1.93 crore toward General Corporate Purposes.
Original exchange filing (PDF)
More announcements from Gaudium IVF and Women Health Ltd
- Gaudium IVF and Women Health Limited has informed the Exchange about audio recording of Earnings Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half .... 路 17 Nov 2026
- Investor Presentation on the Financial Results of the Company for the quarter and half year ended September 30, 2026 路 15 Nov 2026
- Rectification of inadvertent typographical error in the unaudited consolidated financial results for the quarter and half year ended September 30,2026 路 13 Nov 2026
- Gaudium IVF and Women Health Limited has informed the Exchange regarding revised Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information pursuant to Regulation 8(2) of SEBI (PIT) Regulations, 2015. 路 13 Nov 2026
- Revised Code of Practices and Procedures for fair Disclosure of Unpubulished Price Sensitive Information Pursuant to Regulation 8(2) of SEBI (PIT) Regulations, 2015. 路 13 Nov 2026
- Gaudium IVF and Women Health Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 13 Nov 2026
- Statement of Deviation(s) or variation(s) Under Regulation 32 for the quarter ended September 30, 2026. 路 13 Nov 2026
- Press Release on the Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30, 2026 路 13 Nov 2026
